Accumulating evidence from preclinical studies has demonstrated that high levels of neutrophils, platelets, monocytes or C-reactive protein promote tumour progression through the secretion of cytokines and chemokines, while lymphocytes and serum albumin have an anti-tumour effect, stimulating a cytotoxic immune response to cancer. The gene discussed is CRP; the disease is cancer.